Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Bridge to New Markets.

Alzheimer‘s: New approach to inhibit inflammation of the brain

Photo: APA © Photo: APA

The results of studies carried out by team led by Robert Zimmermann of the Institute for Molecular Biosciences were published in the latest issue of the scientific journal "The Journal of Biological Chemistry". In their experiments, they showed that the enzyme MGL can split so-called arachidonyl-glycerol, releasing a fatty acid named arachidonic acid, which has an important function in triggering inflammation processes in the body.

The experiments demonstrated that blocking MGL with the help of genetic methods has a positive effect on the arachidonyl-glycerol level, which ultimately inhibits neuroinflammation. However, an overly high level has side effects such as impaired memory, responsiveness and coordination of movement. The artificially induced increase of the arachidonyl-glycerol level is not the optimal approach.

The researchers subsequently investigated those stellate cells involved in releasing the arachidonic acid. These star-like cells, considered only as filling or auxiliary materials in the central nervous system, are responsible for carrying out several functions in the brain. They are involved in the blood-brain-barrier, which means they dock on the blood vessels and check to see which substances are sent by the blood to the organs. The researchers switched off the MGL in the stellate cells and observed that this step already protected the neuronal cells from inflammation. In this case there were no side effects. 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

Austria Map

Find the perfect location for your company

Vienna is the driving force for innovations in our company,
and one of the growth drivers.

Ottobock Austria

Logo
More testimonials

news from the business location Austria

Medical University of Vienna: New therapy option doubles the life span of B-cell lymphoma patients

The so-called CAR-T cell therapy is a promising option for treating around one fifth of patients with diffuse large B-cell lymphoma.

Ski Tourism as an Attractive Business Driver in Austria

Famous for its culture and unspoiled natural environment, Austria attracts vacationers and tourism companies from all over the world. One major advantage is the central location in the heart of Europe and the related good accessibility.

More news All blog posts